RTR242
Asset
Oral small molecule that boosts autophagic flux to restart autophagy
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Autophagy
- 1
- Indication
- 1
- Trial
- 1
- Developer
Indications
1Alzheimer's disease
Phase 1, Recruiting, ACTRN12625001274460, anzctr.org.au, 8 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials1
- Evidence for its targets1
- Competitors12
- Aging relevance1
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.